Published in
Elsevier, European Journal of Cancer, (101), p. 236-243, 2018
DOI: 10.1016/j.ejca.2018.06.034
Links
Tools
Outcomes by line of therapy and programmed death ligand 1 expression in patients with advanced melanoma treated with pembrolizumab or ipilimumab in KEYNOTE-006: A randomised clinical trial
Journal article published in 2018 by
Matteo S. Carlino 
,
Pascal Wolter,
Honghong Zhou,
Georgina V. Long ,
Dirk Schadendorf ,
Caroline Robert,
Antoni Ribas ,
Erika Richtig,
Marta Nyakas,
Christoph Hoeller,
Gil Bar-Sela ,
Christian Caglevic,
Catherine Barrow,
Ahmed Tarhini,
Christian Blank
and other authors.
,
Pascal Wolter,
Honghong Zhou,
Georgina V. Long ,
Dirk Schadendorf ,
Caroline Robert,
Antoni Ribas ,
Erika Richtig,
Marta Nyakas,
Christoph Hoeller,
Gil Bar-Sela ,
Christian Caglevic,
Catherine Barrow,
Ahmed Tarhini,
Christian Blank
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 